People on the Move

Biogen Will Have a New Global Headquarters and Innovation Hub in Kendall Square in Cambridge, MA

March 25, 2025

Symbiosis Pharmaceutical Services Completes Successful FDA Regulatory Inspection

March 23, 2025

Greenberg Traurig’s Life Sciences & Medical Technology Group Named Finalist for Three LSPN Awards

March 21, 2025

THIS WEEK'S STORIES

Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Mortality, Hospitalizations, and Urgent Heart Failure in Patients with ATTR-CM

March 23, 2025

Agenus Releases Findings in National Colorectal Cancer Survey

March 19, 2025

Sabra Health Care REIT, Inc. Announces Chief Investment Officer Transition

March 24, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Sabra Health Care REIT, Inc. Announces Chief Investment Officer Transition

Cardurion Pharmaceuticals Appoints Karen Lewis as Chief People Officer

Frazier Life Sciences Promotes Anna Chen to Partner

Seek Labs Appoints Kim Wirthlin as Chief Strategy Officer

Culina Health Expands its Leadership Team, Appoints Jane Mentz as Chief Operating Officer

Most Read

Biogen Will Have a New Global Headquarters and Innovation Hub in Kendall Square in Cambridge, MA

ABI-LAB: A Remarkable Life Sciences Facilities Story Amid Turbulent Times

BostonGene to Participate in the 114th Annual Meeting of the United States and Canadian Academy of Pathology

Fujifilm Partners with Us2.ai to Provide AI-Automated Echocardiography Analysis

EDITOR PICKS

Biogen Will Have a New Global Headquarters and Innovation Hub in Kendall Square in Cambridge, MA

Symbiosis Pharmaceutical Services Completes Successful FDA Regulatory Inspection

Greenberg Traurig’s Life Sciences & Medical Technology Group Named Finalist for Three LSPN Awards

THIS WEEK'S STORIES

Alnylam Announces FDA Approval of AMVUTTRA® (vutrisiran), the First RNAi Therapeutic to Reduce Cardiovascular Mortality, Hospitalizations, and Urgent Heart Failure in Patients with ATTR-CM

Agenus Releases Findings in National Colorectal Cancer Survey

Sabra Health Care REIT, Inc. Announces Chief Investment Officer Transition

POPULAR CATEGORY

ABOUT US

FOLLOW US